(3R,4S)-1-benzyl-N,4-di-methylpiperidin-3-amine dihydrochloride
Tofacitinib Impurity 14 is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
Buy 2101951-13-5 Purchase 2101951-13-5 Order 2101951-13-5 Enquire 2101951-13-5 2101951-13-5 price 2101951-13-5 supplier 2101951-13-5 manufacturer 2101951-13-5 exporter Tofacitinib Impurity 14 for method validation Tofacitinib Impurity 14 reference standard Tofacitinib Impurity 14 for ANDA filing Tofacitinib Impurity 14 for forced degradation studies Tofacitinib Impurity 14 identification standard Tofacitinib Impurity 14 for DMF filing Tofacitinib Impurity 14 HPLC standard Tofacitinib Impurity 14 supplier Tofacitinib Impurity 14 manufacturer Tofacitinib Impurity 14 distributor
